Gyre Therapeutics logo

Gyre Therapeutics Share Price Today

(NASDAQ: GYRE)

Gyre Therapeutics share price is $8.88 & ₹758.93 as on 18 Apr 2025, 2.30 'hrs' IST

$8.88

0.94

(11.84%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Gyre Therapeutics share price in Dollar and Rupees. Guide to invest in Gyre Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Gyre Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Gyre Therapeutics share price movements

  • Today's Low: $7.92
    Today's High: $8.97

    Day's Volatility :11.71%

  • 52 Weeks Low: $6.11
    52 Weeks High: $19.00

    52 Weeks Volatility :67.84%

Gyre Therapeutics (GYRE) Returns

PeriodGyre Therapeutics IncIndex (Russel 2000)
3 Months
-18.98%
0.0%
6 Months
-37.24%
0.0%
1 Year
-42.75%
0.0%
3 Years
31.95%
-12.9%

Gyre Therapeutics (GYRE) Key Statistics

in dollars & INR

Previous Close
$7.94
Open
$7.92
Today's High
$8.97
Today's Low
$7.92
Market Capitalization
$831.3M
Today's Volume
$103.3K
52 Week High
$19.0
52 Week Low
$6.11
Revenue TTM
$105.8M
EBITDA
$17.8M
Earnings Per Share (EPS)
$0.05
PE Ratio
177.6
Profit Margin
11.43%
Quarterly Earnings Growth YOY
-0.74%
Return On Equity TTM
20.24%

How to invest in Gyre Therapeutics Stock (GYRE) from India?

It is very easy for Indian residents to invest directly in Gyre Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Gyre Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Gyre Therapeutics or GYRE on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Gyre Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Gyre Therapeutics shares which would translate to 0.096 fractional shares of Gyre Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Gyre Therapeutics, in just a few clicks!

Returns in Gyre Therapeutics (GYRE) for Indian investors in Rupees

The Gyre Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Gyre Therapeutics investment value today

Current value as on today

₹59,594

Returns

₹40,406

(-40.41%)

Returns from Gyre Therapeutics Stock

₹42,747 (-42.75%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Gyre Therapeutics (GYRE)

500%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Gyre Therapeutics Stock from India on INDmoney has increased by 500% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Gyre Therapeutics

Rating
Trend

Sell

    0%Buy

    50%Hold

    50%Sell

Based on 6 Wall street analysts offering stock ratings for Gyre Therapeutics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Gyre Therapeutics Stock (GYRE)

What analysts predicted

Upside of 125.23%

Target:

$20.00

Current:

$8.88

Insights on Gyre Therapeutics Stock (Ticker Symbol: GYRE)

  • Price Movement

    In the last 7 days, GYRE stock has moved up by 5.6%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 25.22M → 27.87M (in $), with an average increase of 4.8% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, 3.52M → 12.47M (in $), with an average increase of 44.7% per quarter
  • GYRE vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 76.1% return, outperforming this stock by 124.9%
  • Price to Sales

    ForGYRE every $1 of sales, investors are willing to pay $7.1, whereas for Beone Medicines Ltd, the investors are paying $6.4 for every $1 of sales.

Gyre Therapeutics Technicals Summary

Sell

Neutral

Buy

Gyre Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Gyre Therapeutics (GYRE) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Gyre Therapeutics Inc logo
-22.31%
-37.24%
-42.75%
31.95%
31.95%
Regeneron Pharmaceuticals, Inc. logo
-17.1%
-41.85%
-37.2%
-21.74%
-0.85%
Beone Medicines Ltd logo
-13.12%
5.03%
78.34%
40.23%
43.44%
Vertex Pharmaceuticals Incorporated logo
-4.76%
2.3%
24.05%
71.43%
78.99%
Alnylam Pharmaceuticals, Inc. logo
-9.09%
-19.67%
62.43%
39.66%
61.91%

About Gyre Therapeutics

Gyre Therapeutics, Inc., a pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis. The company offers ETUARY (Pirfenidone), an anti-fibrotic drug approved for the treatment of idiopathic pulmonary fibrosis; and under Phase 3 trials for the treatment of pneumoconiosis. It is also involved in the development of F351 (Hydronidone), a structural derivative of ETUARY, under Phase 3 trials for the treatment of chronic hepatitis B (CHB)-associated liver fibrosis; and completed Phase 1 trials for the treatment of liver fibrosis associated with metabolic dysfunction-associated steatohepatitis. In addition, the company develops F573 is in Phase 2 clinical trials for the treatment of acute/acute-on-chronic liver failure. Further, its preclinical products include F230 for the treatment of pulmonary arterial hypertension; and F528 to treat chronic obstructive pulmonary disease. The company was founded in 2002 and is headquartered in San Diego, California. Gyre Therapeutics, Inc. operates as a subsidiary of GNI USA, Inc.
Organization
Gyre Therapeutics
Employees
579
CEO
Dr. Han Ying Ph.D.
Industry
Miscellaneous

Management People of Gyre Therapeutics

NameTitle
Mr. Songjiang Ma
President & Chairman
Dr. Han Ying Ph.D.
CEO & Director
Ms. Ruoyu Chen
Chief Financial Officer
Mr. Weiguo Ye
Chief Operating Officer

Important FAQs about investing in GYRE Stock from India :

What is Gyre Therapeutics share price today?

Gyre Therapeutics share price today stands at $8.88, Open: $7.92 ; Previous Close: $7.94 ; High: $8.97 ; Low: $7.92 ; 52 Week High: $19.00 ; 52 Week Low: $6.11.

The stock opens at $7.92, after a previous close of $7.94. The stock reached a daily high of $8.97 and a low of $7.92, with a 52-week high of $19.00 and a 52-week low of $6.11.

Can Indians buy Gyre Therapeutics shares?

Yes, Indians can invest in the Gyre Therapeutics (GYRE) from India.

With INDmoney, you can buy Gyre Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Gyre Therapeutics at zero transaction cost.

How can I buy Gyre Therapeutics shares from India?

It is very easy to buy Gyre Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Gyre Therapeutics (GYRE) be purchased?

Yes, you can buy fractional shares of Gyre Therapeutics with INDmoney app.

What are the documents required to start investing in Gyre Therapeutics stocks?

To start investing in Gyre Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Gyre Therapeutics Stock (GYRE)?

Today’s highest price of Gyre Therapeutics (GYRE) is $8.97.

Today’s lowest price of Gyre Therapeutics (GYRE) is $7.92.

What is today's market capitalisation of Gyre Therapeutics?

Today's market capitalisation of Gyre Therapeutics GYRE is 831.3M

What is the 52 Week High and Low Range of Gyre Therapeutics Stock (GYRE)?

  • 52 Week High

    $19.00

  • 52 Week Low

    $6.11

What are the historical returns of Gyre Therapeutics (GYRE)?

  • 1 Month Returns

    -22.31%

  • 3 Months Returns

    -37.24%

  • 1 Year Returns

    -42.75%

  • 5 Years Returns

    31.95%

Who is the Chief Executive Officer (CEO) of Gyre Therapeutics ?

Dr. Han Ying Ph.D. is the current Chief Executive Officer (CEO) of Gyre Therapeutics.